A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a $10 million investment from several life sciences companies.

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...

DCN Dx, specializing in IVD CDMO and CRO services, has launched Regulatory Affairs Services, a new solution designed to help clients navigate complex regulatory pathways efficiently and successfully.

ARLINGTON, Va., March 13, 2025 /PRNewswire-PRWeb/ -- The National Association of Chain Drug Stores (NACDS) today announced the promotion of Marilyn Hunter to vice president of meetings and conferences ...

C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

The cannabidiol (CBD) world can feel huge and complicated, but products like CBD gummies make it more approachable for some folks. CBD gummies are easy to dose, portable, and discreet. They also ...

Following sales beginning in Australia in March and Japan in April, it will also be available at Walmart, the largest retail chain in the U.S., in June. A representative from Nongshim noted ...

This work proposes a novel gesture recognition system that integrates a triboelectric sensor array (GR-TENG), an A/D conversion module, and a deep learning-based recognition model, addressing these ...

First Global Regulatory Approval of PrecivityAD2 for Use as an In-Vitro Diagnostic to Aid in the Diagnosis of Alzheimer’s Disease The PrecivityAD2 blood test is an analytically and clinically ...

NEW YORK – Neurology firm C2N Diagnostics said Monday that its PrecivityAD2 Alzheimer's blood test has received medical device registration from the UK's Medicines and Healthcare products Regulatory ...